HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hui-Rong Liu Selected Research

Moxibustion

10/2014Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.
8/2014Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.
1/2013Warming Moxibustion Relieves Chronic Visceral Hyperalgesia in Rats: Relations to Spinal Dynorphin and Orphanin-FQ System.
12/2012Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitis.
9/2012Moxibustion inhibits apoptosis and tumor necrosis factor-alpha/tumor necrosis factor receptor 1 in the colonic epithelium of Crohn's disease model rats.
12/2011Moxibustion down-regulates colonic epithelial cell apoptosis and repairs tight junctions in rats with Crohn's disease.
2/2011Suspended moxibustion relieves chronic visceral hyperalgesia and decreases hypothalamic corticotropin-releasing hormone levels.
8/2010Effects of moxibustion on dynorphin and endomorphin in rats with chronic visceral hyperalgesia.
10/2009Down-regulation of protein and mRNA expression of IL-8 and ICAM-1 in colon tissue of ulcerative colitis patients by partition-herb moxibustion.
9/2009Herb-partition moxibustion relieves chronic visceral hyperalgesia and 5-HT concentration in colon mucosa of rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hui-Rong Liu Research Topics

Disease

6Hyperalgesia
06/2015 - 02/2009
6Ischemia
03/2014 - 07/2007
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
06/2015 - 06/2008
5Hypersensitivity (Allergy)
06/2015 - 06/2008
5Ulcerative Colitis
12/2012 - 03/2004
4Myocardial Ischemia (Ischemic Heart Diseases)
07/2007 - 04/2004
3Crohn Disease (Crohn's Disease)
08/2014 - 12/2011
3Anoxia (Hypoxia)
06/2013 - 08/2010
3Hypercholesterolemia
07/2012 - 12/2003
2Pre-Eclampsia (Preeclampsia)
05/2015 - 01/2013
2Proteinuria
05/2015 - 04/2014
2Diarrhea
10/2014 - 06/2008
2Myocardial Infarction
07/2012 - 02/2009
2Reperfusion Injury
07/2012 - 08/2010
2Atherosclerosis
04/2004 - 12/2003
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
05/2015
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2014
1Cardiovascular Diseases (Cardiovascular Disease)
04/2014
1Type 2 Diabetes Mellitus (MODY)
03/2014
1Abdominal Pain (Pain, Abdominal)
01/2013
1Neoplasms (Cancer)
01/2013
1Infection
07/2011
1Pain (Aches)
08/2010
1Cardiac Arrhythmias (Arrythmia)
08/2010
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
04/2010
1Wounds and Injuries (Trauma)
03/2010
1Heart Injuries
02/2009
1Heart Diseases (Heart Disease)
02/2009
1Hypertension (High Blood Pressure)
02/2006
1Multiple Organ Failure (MODS)
06/2005
1Shock
06/2005
1Renal Hypertension
12/2004
1Renovascular Hypertension (Goldblatt Syndrome)
12/2004

Drug/Important Bio-Agent (IBA)

5AutoantibodiesIBA
05/2015 - 12/2004
3Corticotropin-Releasing HormoneIBA
06/2015 - 11/2009
3PPAR gammaIBA
02/2009 - 12/2003
2Messenger RNA (mRNA)IBA
06/2015 - 10/2009
2Dynorphins (Dynorphin)IBA
01/2013 - 08/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 09/2012
2Caspase 3 (Caspase-3)IBA
07/2012 - 02/2009
2Immunoglobulin G (IgG)IBA
07/2011 - 08/2010
2ThioredoxinsIBA
08/2010 - 08/2004
2Peroxidase (Myeloperoxidase)IBA
03/2010 - 02/2009
2Serotonin (5 Hydroxytryptamine)IBA
09/2009 - 02/2009
1Type 1 Angiotensin ReceptorIBA
05/2015
1AldosteroneIBA
05/2015
1SASIBA
10/2014
1Glucose (Dextrose)FDA LinkGeneric
04/2014
1Sucrose (Saccharose)IBA
03/2014
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2013
1nociceptinIBA
01/2013
1Ovarian epithelial cancerIBA
01/2013
1Interleukin-12 (IL 12)IBA
12/2012
1Type II Tumor Necrosis Factor ReceptorsIBA
09/2012
1Type I Tumor Necrosis Factor ReceptorsIBA
09/2012
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
09/2012
1Creatine Kinase (Creatine Phosphokinase)IBA
07/2012
1Protein Kinases (Protein Kinase)IBA
08/2010
1Adrenergic Receptors (Adrenergic Receptor)IBA
08/2010
1Pyruvaldehyde (Methylglyoxal)IBA
08/2010
1B-Cell Activating FactorIBA
04/2010
1Procollagen-Proline Dioxygenase (Prolyl Hydroxylase)IBA
01/2010
1oxalylglycineIBA
01/2010
1Substance PIBA
11/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2009
1Interleukin-8 (Interleukin 8)IBA
10/2009
1Eosine Yellowish-(YS) (Eosin)IBA
06/2008
1Hematoxylin (Haematoxylon)IBA
06/2008
1Reactive Nitrogen SpeciesIBA
07/2007
1Arginine (L-Arginine)FDA Link
07/2007
1CytokinesIBA
02/2007
1AntigensIBA
02/2007
1Desoxycorticosterone (DOCA)FDA Link
02/2006
1OxygenIBA
06/2005
1NitrogenIBA
06/2005
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2005
1UCF 101IBA
01/2005
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2004
1rosiglitazone (Avandia)FDA Link
04/2004
1Proteins (Proteins, Gene)IBA
03/2004
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2003

Therapy/Procedure

14Moxibustion
10/2014 - 03/2004
3Electroacupuncture
06/2015 - 02/2007
2Ischemic Postconditioning
06/2013 - 07/2012
1Aftercare (After-Treatment)
06/2015
1Acupuncture Points (Acupuncture Point)
06/2015
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2013
1Surgical Instruments (Clip)
02/2006